Share Price and Basic Stock Data
Last Updated: October 8, 2025, 10:44 pm
| PEG Ratio | 1.89 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
AccelerateBS India Ltd, based in Mumbai, operates in the office space industry. The company’s market presence is reflected in its MarketCap of ₹27.4 Cr. Analyzing the quarterly and annual sales trends, we observe a consistent growth pattern, with sales showing a steady increase. Operating profit margins (OPM) stand at 27.76%, indicating efficient cost management. Expenses seem well-controlled, leading to a positive net profit of ₹0.73 Cr. The company’s ability to generate revenue and manage costs effectively is evident in its financial performance.
Profitability and Efficiency Metrics
In terms of profitability and efficiency, AccelerateBS India Ltd exhibits solid metrics. With a P/E ratio of 37.6 and ROE of 17.6%, the company shows good returns to shareholders. ROCE at 22.2% signifies efficient capital utilization. Interest coverage ratio of 568.86x indicates the company’s ability to meet interest obligations comfortably. The Cash Conversion Cycle (CCC) of 106.21 days reflects efficient working capital management. These metrics, when compared to sector norms, depict a financially stable and efficient operation.
Balance Sheet Strength and Financial Ratios
The company’s balance sheet strength is highlighted by reserves of ₹0.93 Cr and borrowings of ₹1.73 Cr. The Price-to-Book Value (P/BV) ratio of 9.94x suggests the stock may be undervalued. The Interest Coverage Ratio (ICR) at 568.86x indicates a robust ability to service debt. The current ratio and quick ratio from the data indicate healthy liquidity levels. AccelerateBS India Ltd seems to have a well-managed balance sheet with moderate leverage and strong solvency.
Shareholding Pattern and Investor Confidence
Promoters hold a significant stake of 71.00%, showing a strong belief in the company’s prospects. While FIIs and DIIs data are not available, public shareholding stands at 29.00%. Changes in the shareholding pattern can influence market perception and valuation. A consistent promoter holding and potential institutional interest can enhance investor confidence and valuation multiples, signaling positive market sentiment towards the company.
Outlook, Risks, and Final Insight
Looking ahead, AccelerateBS India Ltd’s growth prospects seem promising. Key drivers may include expanding market presence, innovative product offerings, and strategic partnerships. Risks such as economic downturns, industry competition, and regulatory changes could impact future performance. By maintaining operational efficiency, managing risks prudently, and capitalizing on growth opportunities, the company can strengthen its position in the market. In conclusion, AccelerateBS India Ltd appears well-positioned for sustainable growth, backed by strong financial fundamentals and a positive market outlook.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of AccelerateBS India Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| AccelerateBS India Ltd | 26.1 Cr. | 76.0 | 221/76.0 | 35.8 | 12.7 | 1.32 % | 22.2 % | 17.6 % | 10.0 |
| Industry Average | 0 Cr | 76.00 | 35.80 | 12.70 | 1.32% | 22.20% | 17.60% | 10.00 |
Quarterly Result
| Metric | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Sales | 2.80 | 2.71 | 4.08 | 3.24 | 3.53 |
| Expenses | 2.09 | 2.16 | 2.74 | 3.02 | 2.55 |
| Operating Profit | 0.71 | 0.55 | 1.34 | 0.22 | 0.98 |
| OPM % | 25.36% | 20.30% | 32.84% | 6.79% | 27.76% |
| Other Income | 0.04 | -0.89 | 0.01 | 0.02 | 0.03 |
| Interest | 0.04 | 0.01 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.06 | 0.07 | 0.07 | 0.06 | 0.08 |
| Profit before tax | 0.65 | -0.42 | 1.28 | 0.18 | 0.93 |
| Tax % | 10.77% | 30.95% | 53.12% | 27.78% | 35.48% |
| Net Profit | 0.58 | -0.56 | 0.59 | 0.13 | 0.60 |
| EPS in Rs | 1.87 | -1.65 | 1.74 | 0.38 | 1.75 |
Last Updated: May 31, 2025, 7:12 am
Below is a detailed analysis of the quarterly data for AccelerateBS India Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 3.53 Cr.. The value appears strong and on an upward trend. It has increased from 3.24 Cr. (Sep 2024) to 3.53 Cr., marking an increase of 0.29 Cr..
- For Expenses, as of Mar 2025, the value is 2.55 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.02 Cr. (Sep 2024) to 2.55 Cr., marking a decrease of 0.47 Cr..
- For Operating Profit, as of Mar 2025, the value is 0.98 Cr.. The value appears strong and on an upward trend. It has increased from 0.22 Cr. (Sep 2024) to 0.98 Cr., marking an increase of 0.76 Cr..
- For OPM %, as of Mar 2025, the value is 27.76%. The value appears strong and on an upward trend. It has increased from 6.79% (Sep 2024) to 27.76%, marking an increase of 20.97%.
- For Other Income, as of Mar 2025, the value is 0.03 Cr.. The value appears strong and on an upward trend. It has increased from 0.02 Cr. (Sep 2024) to 0.03 Cr., marking an increase of 0.01 Cr..
- For Interest, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00 Cr..
- For Depreciation, as of Mar 2025, the value is 0.08 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.06 Cr. (Sep 2024) to 0.08 Cr., marking an increase of 0.02 Cr..
- For Profit before tax, as of Mar 2025, the value is 0.93 Cr.. The value appears strong and on an upward trend. It has increased from 0.18 Cr. (Sep 2024) to 0.93 Cr., marking an increase of 0.75 Cr..
- For Tax %, as of Mar 2025, the value is 35.48%. The value appears to be increasing, which may not be favorable. It has increased from 27.78% (Sep 2024) to 35.48%, marking an increase of 7.70%.
- For Net Profit, as of Mar 2025, the value is 0.60 Cr.. The value appears strong and on an upward trend. It has increased from 0.13 Cr. (Sep 2024) to 0.60 Cr., marking an increase of 0.47 Cr..
- For EPS in Rs, as of Mar 2025, the value is 1.75. The value appears strong and on an upward trend. It has increased from 0.38 (Sep 2024) to 1.75, marking an increase of 1.37.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: July 22, 2025, 2:40 pm
| Metric | Mar 2023n n 7m | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Sales | 2.80 | 6.78 | 6.77 |
| Expenses | 2.12 | 4.87 | 5.51 |
| Operating Profit | 0.68 | 1.91 | 1.26 |
| OPM % | 24.29% | 28.17% | 18.61% |
| Other Income | 0.07 | -0.89 | 0.05 |
| Interest | 0.05 | 0.02 | 0.06 |
| Depreciation | 0.06 | 0.15 | 0.14 |
| Profit before tax | 0.64 | 0.85 | 1.11 |
| Tax % | 40.62% | 97.65% | 34.23% |
| Net Profit | 0.39 | 0.03 | 0.73 |
| EPS in Rs | 1.26 | 0.09 | 2.12 |
| Dividend Payout % | 0.00% | 0.00% | 47.12% |
YoY Net Profit Growth
| Year | 2024-2025 |
|---|---|
| YoY Net Profit Growth (%) | 2333.33% |
| Change in YoY Net Profit Growth (%) | 0.00% |
AccelerateBS India Ltd has shown a consistent positive trend in YoY Net Profit Growth (%) in the last 1 years from 2024-2025 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 83% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -54% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 18% |
Last Updated: September 5, 2025, 2:01 pm
Balance Sheet
Last Updated: July 25, 2025, 2:00 pm
| Month | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Equity Capital | 1.96 | 2.15 | 3.44 |
| Reserves | 0.22 | 1.76 | 0.93 |
| Borrowings | 0.33 | 0.54 | 1.73 |
| Other Liabilities | 0.40 | 0.40 | 0.95 |
| Total Liabilities | 2.91 | 4.85 | 7.05 |
| Fixed Assets | 0.51 | 0.40 | 0.33 |
| CWIP | 0.00 | 0.00 | 0.59 |
| Investments | 0.60 | 0.00 | 0.00 |
| Other Assets | 1.80 | 4.45 | 6.13 |
| Total Assets | 2.91 | 4.85 | 7.05 |
Below is a detailed analysis of the balance sheet data for AccelerateBS India Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 3.44 Cr.. The value appears strong and on an upward trend. It has increased from 2.15 Cr. (Mar 2024) to 3.44 Cr., marking an increase of 1.29 Cr..
- For Reserves, as of Mar 2025, the value is 0.93 Cr.. The value appears to be declining and may need further review. It has decreased from 1.76 Cr. (Mar 2024) to 0.93 Cr., marking a decrease of 0.83 Cr..
- For Borrowings, as of Mar 2025, the value is 1.73 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 0.54 Cr. (Mar 2024) to 1.73 Cr., marking an increase of 1.19 Cr..
- For Other Liabilities, as of Mar 2025, the value is 0.95 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.40 Cr. (Mar 2024) to 0.95 Cr., marking an increase of 0.55 Cr..
- For Total Liabilities, as of Mar 2025, the value is 7.05 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4.85 Cr. (Mar 2024) to 7.05 Cr., marking an increase of 2.20 Cr..
- For Fixed Assets, as of Mar 2025, the value is 0.33 Cr.. The value appears to be declining and may need further review. It has decreased from 0.40 Cr. (Mar 2024) to 0.33 Cr., marking a decrease of 0.07 Cr..
- For CWIP, as of Mar 2025, the value is 0.59 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 0.59 Cr., marking an increase of 0.59 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2025, the value is 6.13 Cr.. The value appears strong and on an upward trend. It has increased from 4.45 Cr. (Mar 2024) to 6.13 Cr., marking an increase of 1.68 Cr..
- For Total Assets, as of Mar 2025, the value is 7.05 Cr.. The value appears strong and on an upward trend. It has increased from 4.85 Cr. (Mar 2024) to 7.05 Cr., marking an increase of 2.20 Cr..
However, the Borrowings (1.73 Cr.) are higher than the Reserves (0.93 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2023n n 7m | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Free Cash Flow | 0.68 | 1.37 | -0.47 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Debtor Days | 110.80 | 103.90 | 106.21 |
| Inventory Days | |||
| Days Payable | |||
| Cash Conversion Cycle | 110.80 | 103.90 | 106.21 |
| Working Capital Days | 79.52 | 108.21 | 115.38 |
| ROCE % | 51.15% | 22.18% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 2.57 | 0.15 | 1.97 | 2.57 | 4.22 |
| Diluted EPS (Rs.) | 2.57 | 0.15 | 1.97 | 2.57 | 4.22 |
| Cash EPS (Rs.) | 2.53 | 0.81 | 2.25 | 2.96 | 4.87 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 12.70 | 18.18 | 11.11 | 10.00 | 10.00 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 12.70 | 18.18 | 11.11 | 10.00 | 10.00 |
| Dividend / Share (Rs.) | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue From Operations / Share (Rs.) | 19.69 | 31.59 | 14.26 | 31.72 | 43.92 |
| PBDIT / Share (Rs.) | 3.64 | 8.94 | 3.81 | 4.29 | 6.79 |
| PBIT / Share (Rs.) | 3.24 | 8.26 | 3.53 | 3.66 | 6.08 |
| PBT / Share (Rs.) | 3.23 | 3.97 | 3.30 | 3.42 | 6.04 |
| Net Profit / Share (Rs.) | 2.13 | 0.14 | 1.97 | 2.33 | 4.15 |
| PBDIT Margin (%) | 18.48 | 28.28 | 26.73 | 13.51 | 15.47 |
| PBIT Margin (%) | 16.46 | 26.14 | 24.74 | 11.54 | 13.83 |
| PBT Margin (%) | 16.43 | 12.56 | 23.11 | 10.78 | 13.75 |
| Net Profit Margin (%) | 10.82 | 0.44 | 13.79 | 7.35 | 9.45 |
| Return on Networth / Equity (%) | 16.79 | 0.78 | 17.70 | 23.33 | 41.50 |
| Return on Capital Employeed (%) | 17.19 | 37.65 | 27.91 | 29.61 | 60.62 |
| Return On Assets (%) | 10.39 | 0.62 | 13.23 | 12.91 | 23.50 |
| Long Term Debt / Equity (X) | 0.39 | 0.13 | 0.11 | 0.23 | 0.00 |
| Total Debt / Equity (X) | 0.39 | 0.13 | 0.11 | 0.40 | 0.23 |
| Asset Turnover Ratio (%) | 1.14 | 1.75 | 1.14 | 1.85 | 2.94 |
| Current Ratio (X) | 10.62 | 31.14 | 4.13 | 2.63 | 1.81 |
| Quick Ratio (X) | 10.62 | 31.14 | 4.13 | 2.63 | 1.81 |
| Interest Coverage Ratio (X) | 568.86 | 202.15 | 16.40 | 17.82 | 193.42 |
| Interest Coverage Ratio (Post Tax) (X) | 334.18 | 100.28 | 9.46 | 10.70 | 119.14 |
| Enterprise Value (Cr.) | 41.82 | 65.99 | 0.00 | 0.00 | 0.00 |
| EV / Net Operating Revenue (X) | 6.18 | 9.72 | 0.00 | 0.00 | 0.00 |
| EV / EBITDA (X) | 33.41 | 34.36 | 0.00 | 0.00 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 6.41 | 9.97 | 0.00 | 0.00 | 0.00 |
| Price / BV (X) | 9.94 | 17.32 | 0.00 | 0.00 | 0.00 |
| Price / Net Operating Revenue (X) | 6.41 | 9.97 | 0.00 | 0.00 | 0.00 |
| EarningsYield | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
After reviewing the key financial ratios for AccelerateBS India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 2.57. This value is below the healthy minimum of 5. It has increased from 0.15 (Mar 24) to 2.57, marking an increase of 2.42.
- For Diluted EPS (Rs.), as of Mar 25, the value is 2.57. This value is below the healthy minimum of 5. It has increased from 0.15 (Mar 24) to 2.57, marking an increase of 2.42.
- For Cash EPS (Rs.), as of Mar 25, the value is 2.53. This value is below the healthy minimum of 3. It has increased from 0.81 (Mar 24) to 2.53, marking an increase of 1.72.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 12.70. It has decreased from 18.18 (Mar 24) to 12.70, marking a decrease of 5.48.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 12.70. It has decreased from 18.18 (Mar 24) to 12.70, marking a decrease of 5.48.
- For Dividend / Share (Rs.), as of Mar 25, the value is 1.00. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 1.00, marking an increase of 1.00.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 19.69. It has decreased from 31.59 (Mar 24) to 19.69, marking a decrease of 11.90.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 3.64. This value is within the healthy range. It has decreased from 8.94 (Mar 24) to 3.64, marking a decrease of 5.30.
- For PBIT / Share (Rs.), as of Mar 25, the value is 3.24. This value is within the healthy range. It has decreased from 8.26 (Mar 24) to 3.24, marking a decrease of 5.02.
- For PBT / Share (Rs.), as of Mar 25, the value is 3.23. This value is within the healthy range. It has decreased from 3.97 (Mar 24) to 3.23, marking a decrease of 0.74.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 2.13. This value is within the healthy range. It has increased from 0.14 (Mar 24) to 2.13, marking an increase of 1.99.
- For PBDIT Margin (%), as of Mar 25, the value is 18.48. This value is within the healthy range. It has decreased from 28.28 (Mar 24) to 18.48, marking a decrease of 9.80.
- For PBIT Margin (%), as of Mar 25, the value is 16.46. This value is within the healthy range. It has decreased from 26.14 (Mar 24) to 16.46, marking a decrease of 9.68.
- For PBT Margin (%), as of Mar 25, the value is 16.43. This value is within the healthy range. It has increased from 12.56 (Mar 24) to 16.43, marking an increase of 3.87.
- For Net Profit Margin (%), as of Mar 25, the value is 10.82. This value exceeds the healthy maximum of 10. It has increased from 0.44 (Mar 24) to 10.82, marking an increase of 10.38.
- For Return on Networth / Equity (%), as of Mar 25, the value is 16.79. This value is within the healthy range. It has increased from 0.78 (Mar 24) to 16.79, marking an increase of 16.01.
- For Return on Capital Employeed (%), as of Mar 25, the value is 17.19. This value is within the healthy range. It has decreased from 37.65 (Mar 24) to 17.19, marking a decrease of 20.46.
- For Return On Assets (%), as of Mar 25, the value is 10.39. This value is within the healthy range. It has increased from 0.62 (Mar 24) to 10.39, marking an increase of 9.77.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.39. This value is within the healthy range. It has increased from 0.13 (Mar 24) to 0.39, marking an increase of 0.26.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.39. This value is within the healthy range. It has increased from 0.13 (Mar 24) to 0.39, marking an increase of 0.26.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.14. It has decreased from 1.75 (Mar 24) to 1.14, marking a decrease of 0.61.
- For Current Ratio (X), as of Mar 25, the value is 10.62. This value exceeds the healthy maximum of 3. It has decreased from 31.14 (Mar 24) to 10.62, marking a decrease of 20.52.
- For Quick Ratio (X), as of Mar 25, the value is 10.62. This value exceeds the healthy maximum of 2. It has decreased from 31.14 (Mar 24) to 10.62, marking a decrease of 20.52.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 568.86. This value is within the healthy range. It has increased from 202.15 (Mar 24) to 568.86, marking an increase of 366.71.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 334.18. This value is within the healthy range. It has increased from 100.28 (Mar 24) to 334.18, marking an increase of 233.90.
- For Enterprise Value (Cr.), as of Mar 25, the value is 41.82. It has decreased from 65.99 (Mar 24) to 41.82, marking a decrease of 24.17.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 6.18. This value exceeds the healthy maximum of 3. It has decreased from 9.72 (Mar 24) to 6.18, marking a decrease of 3.54.
- For EV / EBITDA (X), as of Mar 25, the value is 33.41. This value exceeds the healthy maximum of 15. It has decreased from 34.36 (Mar 24) to 33.41, marking a decrease of 0.95.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 6.41. This value exceeds the healthy maximum of 3. It has decreased from 9.97 (Mar 24) to 6.41, marking a decrease of 3.56.
- For Price / BV (X), as of Mar 25, the value is 9.94. This value exceeds the healthy maximum of 3. It has decreased from 17.32 (Mar 24) to 9.94, marking a decrease of 7.38.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 6.41. This value exceeds the healthy maximum of 3. It has decreased from 9.97 (Mar 24) to 6.41, marking a decrease of 3.56.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in AccelerateBS India Ltd:
- Net Profit Margin: 10.82%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 17.19% (Industry Average ROCE: 22.2%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 16.79% (Industry Average ROE: 17.6%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 334.18
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 10.62
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 35.8 (Industry average Stock P/E: 35.8)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.39
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 10.82%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| IT Consulting & Software | 604, Quantum Tower, Mumbai Maharashtra 400064 | investors@acceleratebs.com http://www.acceleratebs.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Kunal Arvind Shah | Chairman & Managing Director |
| Mr. Keyur Dipakkumar Shah | Whole Time Director |
| Ms. Ami Keyur Shah | Executive Director & CFO |
| Ms. Ishani Kunal Shah | Executive Director |
| Mr. Krunal Bhupendra Katwala | Ind. Non-Executive Director |
| Mr. Pratik Pravin Doshi | Ind. Non-Executive Director |
| Mr. Hardik Naresh Bagadia | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of AccelerateBS India Ltd?
AccelerateBS India Ltd's intrinsic value (as of 10 October 2025) is 64.86 which is 14.66% lower the current market price of 76.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹26.1 Cr. market cap, FY2025-2026 high/low of 221/76.0, reserves of ₹0.93 Cr, and liabilities of 7.05 Cr.
What is the Market Cap of AccelerateBS India Ltd?
The Market Cap of AccelerateBS India Ltd is 26.1 Cr..
What is the current Stock Price of AccelerateBS India Ltd as on 10 October 2025?
The current stock price of AccelerateBS India Ltd as on 10 October 2025 is 76.0.
What is the High / Low of AccelerateBS India Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of AccelerateBS India Ltd stocks is 221/76.0.
What is the Stock P/E of AccelerateBS India Ltd?
The Stock P/E of AccelerateBS India Ltd is 35.8.
What is the Book Value of AccelerateBS India Ltd?
The Book Value of AccelerateBS India Ltd is 12.7.
What is the Dividend Yield of AccelerateBS India Ltd?
The Dividend Yield of AccelerateBS India Ltd is 1.32 %.
What is the ROCE of AccelerateBS India Ltd?
The ROCE of AccelerateBS India Ltd is 22.2 %.
What is the ROE of AccelerateBS India Ltd?
The ROE of AccelerateBS India Ltd is 17.6 %.
What is the Face Value of AccelerateBS India Ltd?
The Face Value of AccelerateBS India Ltd is 10.0.